secwatch.observer — SEC 8-K summary
======================================

Issuer:     GUIDED THERAPEUTICS INC (GTHP)
CIK:        0000924515
Form:       8-K
Filed at:   2022-07-29T23:59:59+00:00
Accession:  0001477932-22-005479
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guided Therapeutics cancels previously approved 1-for-20 reverse stock split, renders amendment void
--------------------------------------------------------------------------------

- Certificate of Correction filed July 25, 2022, nullifies December 30, 2021 reverse split amendment ab initio.
- FINRA never declared the reverse split effective, so it was never implemented on the OTC Market.
- Reverse stock split ratio of up to 1-for-20 was approved by stockholders in July 2021 and board in December 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/924515/000147793222005479/0001477932-22-005479-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/924515/000147793222005479/gthp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-22-005479

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer